Liposomal formulation for oral administration of glutathione (reduced)
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 8, 2013
Grant Date -
May 11, 2006
app pub date -
Nov 6, 2005
filing date -
Nov 7, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention is a composition administrable orally to provide systemic glutathione (reduced) and a method for providing systemic glutathione by oral administration of glutathione (reduced) in a liposome encapsulation. The administration of a therapeutically effective amount of oral liposomal glutathione (reduced) results in improvement of symptoms in disease states related to glutathione deficiency such as Parkinson's disease and cystic fibrosis. Compounds enhancing the effect of the liposomal glutathione are contemplated such as Selenium, EDTA, carbidopa, and levodopa.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully